Objective: To evaluate the treatment effect of genital warts, we investigated the quadrivalent
HPV vaccine injection compared with surgical excision. Materials and Methods: This …

Introduction Human papillomavirus (HPV) is one of the most common sexually transmitted
infections and is the cause of several different diseases in men and women. Although little is …

Background: Various therapeutic modalities have been implemented for wart treatment, with
limited efficacy. Recently, resistant warts treated using quadrivalent human papilloma virus …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts in
young women. Design Population-based study using health databases. Setting Valencian …

Abstract The quadrivalent HPV types 6, 11, 16, 18 vaccine (Gardasil®) is a recombinant
vaccine comprising purified virus-like particles derived from the L1 capsid proteins of HPV …

Human papillomavirus (HPV) vaccines are preventive measures to decrease HPV infection
rates. Knowledge of their efficacy as treatment options for anogenital warts (AGWs) and oral …

Background. Cellular immunity is involved in spontaneous clearance of anogenital warts
caused, most typically, by human papillomavirus (HPV) type 6 or 11, supporting the concept …

Routine vaccination programs have had a substantial impact on reducing the prevalence of
a variety of infectious diseases. In light of the fact that human papillomavirus (HPV) is a …

Papillomaviruses may infect cutaneous and mucosal epithelia, leading to the development
of proliferative lesions in a wide variety of vertebrates. The viruses are usually species …

Human papillomavirus (HPV) types cause approximately 70% of cervical cancer worldwide.
Two vaccines have been recently evaluated in randomized controlled trials: the bivalent …